- Home
- BLBX vs MYNZ Comparison
BLBX vs MYNZ Comparison
Compare BLBX & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLBX
- MYNZ
- Stock Information
- Founded
- BLBX 2014
- MYNZ 2021
- Country
- BLBX United States
- MYNZ Germany
- Employees
- BLBX N/A
- MYNZ N/A
- Industry
- BLBX EDP Services
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- BLBX Technology
- MYNZ Health Care
- Exchange
- BLBX Nasdaq
- MYNZ Nasdaq
- Market Cap
- BLBX 10.6M
- MYNZ 10.5M
- IPO Year
- BLBX N/A
- MYNZ 2021
- Fundamental
- Price
- BLBX $3.49
- MYNZ $3.44
- Analyst Decision
- BLBX
- MYNZ Buy
- Analyst Count
- BLBX 0
- MYNZ 3
- Target Price
- BLBX N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- BLBX 240.1K
- MYNZ 177.3K
- Earning Date
- BLBX 05-14-2025
- MYNZ 04-15-2025
- Dividend Yield
- BLBX N/A
- MYNZ N/A
- EPS Growth
- BLBX N/A
- MYNZ N/A
- EPS
- BLBX N/A
- MYNZ N/A
- Revenue
- BLBX $2,566,946.00
- MYNZ $893,991.00
- Revenue This Year
- BLBX N/A
- MYNZ $20.94
- Revenue Next Year
- BLBX N/A
- MYNZ $18.01
- P/E Ratio
- BLBX N/A
- MYNZ N/A
- Revenue Growth
- BLBX N/A
- MYNZ N/A
- 52 Week Low
- BLBX $1.51
- MYNZ $0.18
- 52 Week High
- BLBX $6.00
- MYNZ $8.20
- Technical
- Relative Strength Index (RSI)
- BLBX 50.52
- MYNZ 37.70
- Support Level
- BLBX $3.07
- MYNZ $2.72
- Resistance Level
- BLBX $3.84
- MYNZ $5.34
- Average True Range (ATR)
- BLBX 0.45
- MYNZ 0.55
- MACD
- BLBX -0.02
- MYNZ -0.12
- Stochastic Oscillator
- BLBX 44.14
- MYNZ 27.48
About BLBX Blackboxstocks Inc.
Blackboxstocks Inc is a financial technology and social media hybrid platform offering real-time proprietary analytics and news for stock and options traders of all levels. Its web-based software (the Blackbox System) employs predictive technology enhanced by artificial intelligence to find volatility and unusual market activity that may result in a rapid change in the price of a stock or option. It provides users with a fully interactive social media platform that is integrated into its dashboard, enabling users to exchange information and ideas quickly and efficiently through a common network. The company introduced a live audio/video feature that allows members to broadcast on their channels to share trading strategies and market insight within the Blackbox community.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.